Home » Topics » Disease categories and therapies » Immune

Immune
RSS

Interferon inducers in development at Hokuriku Seiyaku

June 7, 1999

Licensing opportunity from Cornell Research Foundation: methods of modulating immune responses

June 7, 1999

New class of triterpene immunosuppressants described by Merck

June 4, 1999

Coulter acquires therapeutic antibody from Pharma Pacific

June 4, 1999

Merck presents new class of potassium channel blockers and immunosuppressants

June 2, 1999

NIAID-sponsored scientists on the way to developing a broad-spectrum staph vaccine

June 1, 1999

Abgenix uses XenoMouse technology to generate new antibody for immunologic diseases

May 31, 1999

RotaShield vaccine receives marketing authorization in Europe

May 28, 1999

Use of ET antagonists for transplant rejection described by Knoll

May 27, 1999

SangStat presents new PKC modulator that inhibits transplant rejection in mice

May 27, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 10, 2026.
FENS 2026: Shedding light on the sheddome
BioWorld
At the recently opened FENS Forum 2026 in Barcelona – the Federation of European Neuroscience Societies’ flagship congress and Europe’s largest neuroscience...
FENS 2026: Next-gen biologics take on brain disease
BioWorld
Whether by fine-tuning neurotransmitter signaling or silencing disease-associated genes, emerging biologic therapies are reshaping neuroscience drug development,...
Ionis, AZ shares down on unexpected Wainua flop in cardiomyopathy
BioWorld
News of the unexpected phase III failure of the gene silencing drug Wainua (eplontersen) in the treatment of transthyretin-mediated amyloid cardiomyopathy sent...
NRF2 activators reported in Vailima Peninsula patent
BioWorld Science
Vailima Peninsula Pty Ltd. has discovered new nuclear factor erythroid 2-related factor 2 (NFE2L2; NRF2) activators potentially useful for the treatment of...